Claudio Cavazza - Net Worth and Insider Trading
Claudio Cavazza Net Worth
The estimated net worth of Claudio Cavazza is at least $73 Million dollars as of 2024-09-20. Claudio Cavazza is the 10% Owner of SciClone Pharmaceuticals Inc and owns about 6,580,938 shares of SciClone Pharmaceuticals Inc (SCLN) stock worth over $73 Million. Claudio Cavazza is also the 10% Owner of Regenerx Biopharmaceuticals Inc and owns about 9,846 shares of Regenerx Biopharmaceuticals Inc (RGRX) stock worth over $14. Details can be seen in Claudio Cavazza's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Claudio Cavazza has not made any transactions after 2011-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Claudio Cavazza
Claudio Cavazza Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Claudio Cavazza owns 3 companies in total, including Regenerx Biopharmaceuticals Inc (RGRX) , Soligenix Inc (SNGX) , and SciClone Pharmaceuticals Inc (SCLN) .
Click here to see the complete history of Claudio Cavazza’s form 4 insider trades.
Insider Ownership Summary of Claudio Cavazza
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGRX | Regenerx Biopharmaceuticals Inc | 2011-01-05 | 10 percent owner |
| SNGX | Soligenix Inc | 2008-11-26 | 10 percent owner |
| SCLN | SciClone Pharmaceuticals Inc | 2008-01-30 | 10 percent owner |
Claudio Cavazza Latest Holdings Summary
Claudio Cavazza currently owns a total of 2 stocks. Among these stocks, Claudio Cavazza owns 6,580,938 shares of SciClone Pharmaceuticals Inc (SCLN) as of January 30, 2008, with a value of $73 Million and a weighting of 100%. Claudio Cavazza also owns 9,846 shares of Regenerx Biopharmaceuticals Inc (RGRX) as of January 5, 2011, with a value of $14 and a weighting of 0%.
Latest Holdings of Claudio Cavazza
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SCLN | SciClone Pharmaceuticals Inc | 2008-01-30 | 6,580,938 | 11.15 | 73,377,459 |
| RGRX | Regenerx Biopharmaceuticals Inc | 2011-01-05 | 9,846 | 0.00 | 14 |
Holding Weightings of Claudio Cavazza
Claudio Cavazza Form 4 Trading Tracker
According to the SEC Form 4 filings, Claudio Cavazza has made a total of 0 transactions in SciClone Pharmaceuticals Inc (SCLN) over the past 5 years. The most-recent trade in SciClone Pharmaceuticals Inc is the acquisition of 28,600 shares on January 30, 2008, which cost Claudio Cavazza around $58,630.
According to the SEC Form 4 filings, Claudio Cavazza has made a total of 0 transactions in Regenerx Biopharmaceuticals Inc (RGRX) over the past 5 years. The most-recent trade in Regenerx Biopharmaceuticals Inc is the acquisition of 22,222 shares on January 5, 2011, which cost Claudio Cavazza around $600,000.
Insider Trading History of Claudio Cavazza
- 1
Claudio Cavazza Trading Performance
GuruFocus tracks the stock performance after each of Claudio Cavazza's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Claudio Cavazza is 19.22%. GuruFocus also compares Claudio Cavazza's trading performance to market benchmark return within the same time period. The performance of stocks bought by Claudio Cavazza within 3 months outperforms 14 times out of 26 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Claudio Cavazza's insider trading performs compared to the benchmark.
Performance of Claudio Cavazza
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.39 | | | | | |
| Relative Return to S&P 500(%) | 8.56 | | | | | |
Claudio Cavazza Ownership Network
Claudio Cavazza Owned Company Details
What does Regenerx Biopharmaceuticals Inc do?
Who are the key executives at Regenerx Biopharmaceuticals Inc?
Claudio Cavazza is the 10 percent owner of Regenerx Biopharmaceuticals Inc. Other key executives at Regenerx Biopharmaceuticals Inc include other: Member of 10% owner group Aptafin S P A , 10 percent owner Spa Essetifin , and 10 percent owner Francesca Cavazza .
Regenerx Biopharmaceuticals Inc (RGRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Regenerx Biopharmaceuticals Inc (RGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenerx Biopharmaceuticals Inc Insider Transactions
Claudio Cavazza Mailing Address
Above is the net worth, insider trading, and ownership report for Claudio Cavazza. You might contact Claudio Cavazza via mailing address: Via Sudafrica 20, Rome Italy L6 00000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
